progressive myoclonic epilepsy type 3
progressive myoclonic epilepsy type 3
Explore linked clinical trials. Standard reference: MONDO:00127211 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kufor-Rakeb syndrome, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Neuronal Ceroid-Lipofuscinoses, Nutritional and Metabolic Diseases, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, juvenile neuronal ceroid lipofuscinosis, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, neurodegenerative disease, neuronal ceroid lipofuscinosis 1, neuronal ceroid lipofuscinosis 5, parkinsonism due to ATP13A2 deficiency, progressive myoclonic epilepsy type 3 | Recruiting | Not stated | 2021-10-29 | NCT04613089 |